Genetic mutation test kit Anyplex™ II

tuberculosisMycobacterium tuberculosissputum

Simultaneous detection of MTB, 25 mutations associated with Multi-Drug Resistance tuberculosis (MDR-TB) and 13 mutations associated with Extensively Drug Resistance tuberculosis (XDR-TB) Anyplex™ II MTB/MDR/XDR Detection is a multiplex real-time PCR assay that detect Mycobacterium tuberculosis (MTB) with Ct value and identify 38 mutations associated with Drug-Resistance simultaneously. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control. KEY FEATURES AND BENEFITS Wide range of specimens Wide range of applicable specimens Multiplex real-time PCR Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB Wild-type Control WTC[1](Wild-type Control) and Internal Control (IC) for assay validity DNA extraction solution Reagent for DNA Detection is provided, purchase of DNA extraction kit is unnecessary Prediction of antibiotic resistance Detection and identification of mutations associated antibiotic resistance for appropriate infection control Fast treatment decision Fast treatment decision by simultaneous screening and subtyping Powerful performance with unique technology Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies UDG system Utilization of the UDG system to prevent carry-over contamination Automatic data analyzer Automated data interpretation and LIS interlocking with Seegene Viewer